DPP4 inhibitors could be potential COVID-19 therapy, finds study
New research suggests that the DPP4 enzyme could be a drug target for COVID-19 and DPP4 inhibitors could therefore treat
Read moreCoronavirus disease (COVID-19) news
New research suggests that the DPP4 enzyme could be a drug target for COVID-19 and DPP4 inhibitors could therefore treat
Read moreTobacco and marijuana products damage lungs, where the virus does its harm. Health officials are urging people to quit, and
Read moreNovel ‘learning while doing’ clinical trial approach called REMAP helps doctors find the optimal trade-off between quickly adopting new therapies
Read moreLiquid metals and alloys have exceptional properties that make them suitable for electrical energy storage and generation applications.
Read moreA multidisciplinary team of researchers at the University of Illinois at Urbana-Champaign has developed tiny sensors that measure oxygen transport
Read moreResearchers at Children’s Hospital of Philadelphia (CHOP) have pinpointed a genetic variation responsible for driving the development of inflammatory bowel
Read moreIn the course of every single cell division, the genetic information on the chromosomes must be distributed equally between the
Read more